ENG
KOR
Theragen Bio
Theragen Bio
About Us
Greeting
Mission/Vision
Certificates
CI
Services
Services
NGS
Genome Sequencing
Transcriptome Sequencing
Epigenome Sequencing
Metagenome Sequencing
SNP Microarray
FAQ
Bioinformatics
Genome Sequencing
Transcriptome Sequencing
Epigenome Sequencing
Metagenome Sequencing
Clinical Sequencing
Clinical Sequencing
Bio IT Solutions
NGS LIMS
Healthcare LIMS
Genome Browser
Healthcare
Disease prediction service (HelloGene)
DTC healthcare Service (GeneStyle)
Microbiome analysis service (THERAbiome)
R&D
R&D
R&D
DeepOmics™
DeepOmics™
Neo
Marker
Pipeline Schedule
Achievement
Achievement
Task
Papers
Property
PR Center
PR Center
Notice
Corporate News
Press Release
newsLetter
Subscribe newsLetter
Contact
Contact
Inquiry
FAQ
Careers
Careers
Careers
Careers
Online Application
PR Center
Notice
Corporate News
Press Release
NewsLetter
Subscribe NewsLetter
Press Release
All
Press Releases
Media Room
2022-04-21
[Press Release]Theragen Bio, designated as a clinical trial specimen analysis institution by the Ministry of Food and Drug Safety
2022-04-13
[Press Release]Theragen Bio to launch HelloGene 4.0, a disease prediction genetic test
2022-04-07
[Press Release]Theragen Bio to acquire a patent of AI-Based Patient Classification Molecular Subtype Calculation Device, DeepOmics Marker™
1
2
Subject
Content
Subject + Content
List
Theragen Bio
About Us
Greeting
Mission/Vision
Certificates
CI
Service
NGS
Bioinformatics
Clinical Sequencing
Bio IT Solution
Healthcare
R&D
R&D
DeepOmics™
Pipeline Schedule
Archievement
Task
Papers
Property
PR Center
Notice
Corporate News
Press release
NewLetter
Contact
Inquiry
FAQ
Careers
Careers
Online Application'
CLOSE